Skip to content

Prestige Consumer Healthcare PBH Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Cardinal Health logo
Cardinal HealthCAH
Organon logo
OrganonOGN
Kenvue logo
KenvueKVUE
Abbott logo
AbbottABT
Clorox logo
CloroxCLX
Colgate-Palmolive logo
Colgate-PalmoliveCL

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's common stock, shares authorized (in shares)?
Prestige Consumer Healthcare (PBH) reported common stock, shares authorized (in shares) of $250M in Q4 2025.
How has Prestige Consumer Healthcare's common stock, shares authorized (in shares) changed year-over-year?
Prestige Consumer Healthcare's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $250M to $250M.
What is the long-term trend for Prestige Consumer Healthcare's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Prestige Consumer Healthcare's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $250M to $250M.